A drug with the SMILES NC(=O)C1CCN(C(=O)c2ccc3c(=O)n(Cc4cccc(Br)c4)c(=S)[nH]c3c2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -2.200%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
NC(=O)C1CCN(C(=O)c2ccc3c(=O)n(Cc4cccc(Br)c4)c(=S)[nH]c3c2)CC1
NC(=O)C1CCN(C(=O)c2ccc3c(=O)n(Cc4cccc(Br)c4)c(=S)[nH]c3c2)CC1
1-[3-[(3-bromophenyl)methyl]-4-oxo-2-sulfanylidene-1H-quinazoline-7-carbonyl]piperidine-4-carboxamide